Notable
How Vaborem® is Taking up in the Body and Tolerated · Gram Negative Infections, Including But Not Restricted to Complicated Urinary Tract Infections
Primary and study completion pushed from Jul 2026 to Oct 2027
Menarini GroupPhase 2 NCT06828848 Registry history of NCT06828848 on ClinicalTrials.gov (opens the registry)
Updated